The Rho-associated kinase inhibitor fasudil can replace Y-27632 for use in human pluripotent stem cell research

• Seongjun So,

  Roles Writing – original draft

  Affiliation Stem Cell Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

  http://orcid.org/0000-0002-7281-8771

  ⨯
• Yeonmi Lee,

  Roles Methodology

  Affiliation Stem Cell Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

  ⨯
• Jiwan Choi,

  Roles Methodology

  Affiliation Stem Cell Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

  ⨯
• Seoon Kang,

  Roles Methodology

  Affiliation Stem Cell Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

  ⨯
• Ji-Yoon Lee,

  Roles Methodology

  Affiliation Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

  ⨯
• Julie Hwang,

  Roles Methodology

  Affiliation Stem Cell Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

  ⨯
• Joosung Shin,

  Roles Methodology

  Affiliation Stem Cell Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

  ⨯
• James R. Dutton,

  Roles Resources

  Affiliation Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Eul-Ju Seo,

  Roles Resources

  Affiliation Medical Genetics Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

  ⨯
• Beom Hee Lee,

  Roles Resources

  Affiliation Medical Genetics Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

  ⨯
• Chong Jai Kim,

  Roles Funding acquisition

  Affiliation Department of Pathology, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

  ⨯
• Shoukhrat Mitalipov,

  Roles Resources

  Affiliation Center for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, Oregon, United States of America

  ⨯
• Soo Jin Oh,

  Roles Data curation

  Affiliation Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

  ⨯
• Eunju Kang

  Roles Writing – review & editing

  * E-mail: kangeun@amc.seoul.kr

  Affiliations Stem Cell Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

  http://orcid.org/0000-0002-7240-7868

  ⨯